Systemic silencing of Phd2 causes reversible immune regulatory dysfunction (2019)

First Author: Yamamoto A
Attributed to:  Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci124099

PubMed Identifier: 31162141

Publication URI: http://europepmc.org/abstract/MED/31162141

Type: Journal Article/Review

Parent Publication: Journal of Clinical Investigation

Issue: 9

ISSN: 0021-9738